← Back
Data updated: Jul 17, 2026
VANSEN PHARMA
Pharma Pharmaceuticals
VANSEN PHARMA is a pharmaceutical company with 1 FDA-approved products.
2001
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
VANSEN PHARMA's Key Drugs
VANSEN PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
VANSEN PHARMA's Recent FDA Approvals
New NDA/BLA approvals for VANSEN PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
VANSEN PHARMA's Therapeutic Areas
Disease areas where VANSEN PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
VANSEN PHARMA Pipeline Snapshot
Active clinical trials for VANSEN PHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2001-08-29
- Latest
- 2012-08-06
- Applications
- 1